20th Annual Superbugs & Superdrugs (description)


Address:Copthorne Tara Hotel, Scarsdale Place, Kensington London, , United Kingdom W8 5SY
Event dates:3/19/2018 - 3/20/2018 (This event has already taken place)
Event web site:
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 20th Annual Superbugs & Superdrugs


Topics to be Covered:
Organizer phone:+4402078276000
Offering type:Conference
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:SMi Group
Est. # of exhibitors:
Currency:British Pounds
Language:Data not provided
CE Credits:
Organizer URL


Providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities, SMi presents the established 20th annual Superbugs & Superdrugs conference which will return to Central London on 19th and 20th March 2018.

The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders, drug discovery specialists and government bodies such as MHRA and DNDi.


- Richard Bax, Senior Partner, TranScrip Partners
- Lloyd Czaplewski, Dir, Chemical Biology Ventures
- Mair Powell, Senior Clinical Assessor, MHRA
- Jean-Pierre Paccaud, Dir of Business Development at GARDP, Drugs for Neglected Diseases initiative (DNDi)
- Conrad Lichtenstein, CSO, Nemesis Bioscience
- David Brown, MD & Founder, Alchemy Biomedical Consulting
- Domingo Gargallo-Viola, CSO, ABAC Therapeutics
- John George, CSO, Oppilotech
- Larry Sutton, Scientific Founder, Gladius Pharmaceuticals
- Kathy Talkington, Project Dir, Pew Charitable Trusts
- David Cook, CSO, Blueberry Therapeutics
- William Weiss, Dir of Pre-Clinical Services, UNT Health Science Center
- Cara Cassino, CMO, ContraFect
- Stephen Barat, Head of Pre-Clinical & Early Clinical Development, SCYNEXIS


- Analyze the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR
- Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress
- Learn about regulatory pathways for the registration of new antimicrobial agents
- Evaluate the latest incentives and funding solutions to spur drug discovery
- Explore novel alternatives to antibiotics currently in development

Early birds available online


Time: 8:30 am to 5:30 pm

Registration Fee Details:

Conference + workshop: GBP 2098
Conference: GBP 1499

Other items that tuition includes:

Travel and hotel arrangements:

Contact Person:Teri Arri
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Organizer Phone+4402078276000
Structural makeupData not provided
Host Sponsor; Other SponsorsSMi Group
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Number in attendance of:
Target BoundariesInternational
Is Registration contact information the same as Organizer Contact above?Yes
Web Page
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?NA
Will there be shuttle service available?NA

Sign In/Sign Out
About Us
Contact Us